Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rudolf Dr. Hanko is active.

Publication


Featured researches published by Rudolf Dr. Hanko.


Analytical Biochemistry | 1990

A fluorometric assay for HIV-protease activity using high-performance liquid chromatography

Paul P. Tamburini; Robert N. Dreyer; Jutta Hansen; Jack Letsinger; Jim Elting; Ann Gore-Willse; Robert Dally; Rudolf Dr. Hanko; David G. Osterman; Michael E. Kamarck; Heeja Yoo-Warren

A rapid sensitive method for the quantification of in vitro HIV-protease activity has been developed on the basis of the endoproteolytic conversion of N-Dns-SQ-NYPIV to N-Dns-SQNY. The use of the N-dansyl group as a fluorescence label was shown to not significantly alter the apparent kinetic parameters for the peptide-enzyme interaction. Using fluorescence detection, the dansylated product and unconverted substrate are detected in a single rapid (3 min) isocratic reverse-phase HPLC separation in quantities as low as 0.2 pmol. The method is highly reproducible and suited to a variety of applications including the analysis of large sample numbers and rigorous enzymological studies.


Archive | 1994

Benzofuranyl-and-thiophenyl-alkanecarboxyclic acid derivatives

Rüdiger Fischer; Gabriele Bräunlich; Klaus-Helmut Mohrs; Rudolf Dr. Hanko; John-Edward Butler-Ransohoff; Mazen Es-Sayed; Graham Dr Sturton; Steve Tudhope; Trevor Dr Abram; Wendy J Dr Mcdonald-Gibson


Archive | 1995

Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives

Trevor Dr Abram; Gabriele Bräunlich; Mazen Es-Sayed; Rüdiger Fischer; Mary F. Fitzgerald; Rudolf Dr. Hanko; Graham Dr Sturton; Stephen Dr Tudhope


Archive | 1992

Substituted biphenylpyridinones as angiotensin II antagonists

Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Johannes-Peter Stasch; Andreas Dr. Knorr; Stefan Wohlfeil; Walter Dr. Hübsch; Jürgen Dr. Dressel; Peter Fey; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Siegfried Zaiss


Archive | 1995

Oxalylamino-benzofuran- and benzothienyl-derivatives

Gabriele Bräunlich; Rüdiger Fischer; Mazen Es-Sayed; Rudolf Dr. Hanko; Stephen Dr Tudhope; Graham Dr Sturton; Trevor Dr Abram; Wendy J Dr Mcdonald-Gibson; Mary F. Fitzgerald


Archive | 1992

Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application

Ulrich Dr. Müller; Klaus Mohrs; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Walter Dr. Hübsch; Michael Matzke; Ulrich Niewohner; Siegfried Raddatz; Thomas Dr. Krämer; Matthias Dr. Müller-Gliemann; Hans-Peter Dr. Bellemann; Martin Dr. Beuck; Stanislav Kazda; Stefan Wohlfeil


Archive | 1995

Amino-benzofuryl-and thienyl-derivatives

Trevor Dr Abram; Gabriele Bräunlich; Mazen Es-Sayed; Rüdiger Fischer; Mary F. Fitzgerald; Rudolf Dr. Hanko; Wendy J Dr Mcdonald-Gibson; Graham Dr Sturton; Stephen Dr Tudhope


Archive | 1993

Sulphonylbenzyl-substituted pyridones which are angiotension II receptor antagonists

Rudolf Dr. Hanko; Walter Dr. Hübsch; Jürgen Dr. Dressel; Peter Fey; Thomas Dr. Krämer; Ulrich Dr. Müller; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Stanislav Kazda; Claudia Hirth-Dietrich; Andreas Knorr; Johannes-Peter Stasch; Stefan Wohlfeil; Özkan Dr. Yalkinoglu


Archive | 1994

Substituted mono- and bipyridylmethylpyridones

Peter Fey; Walter Dr. Hübsch; Jürgen Dr. Dressel; Rudolf Dr. Hanko; Thomas Dr. Krämer; Ulrich Dr. Müller; Matthias Dr. Müller-Gliemann; Martin Dr. Beuck; Hilmar Bischoff; Stefan Wohlfeil; Dirk Denzer; Stanislav Kazda; Johannes-Peter Stasch; Andreas Knorr; Siegfried Zaiss


Archive | 1995

hIL-4 mutant proteins used as antagonists or partial agonists of human interleukin 4

Hanno Wild; Rudolf Dr. Hanko; Michael Dorschug; Hans-Dietrich Dr. Hörlein; Jurgen Beunink; Heiner Apeler; Hermann Wehlmann; Walter Sebald

Researchain Logo
Decentralizing Knowledge